Form 8-K - Current report:
SEC Accession No. 0001564590-20-011164
Filing Date
2020-03-16
Accepted
2020-03-16 16:15:30
Documents
4
Period of Report
2020-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20200316.htm 8-K 32106
2 EX-99.1 onct-ex991_7.htm EX-99.1 48829
3 GRAPHIC gcxnzr43szuz000002.jpg GRAPHIC 3681
4 GRAPHIC gcxnzr43szuz000001.jpg GRAPHIC 5357
  Complete submission text file 0001564590-20-011164.txt   94931
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 20717311
SIC: 2834 Pharmaceutical Preparations